Impact of Anatomical and Viability-Guided Completeness of Revascularization on Clinical Outcomes in Ischemic Cardiomyopathy
Saad Ezad(King's College London), P. E. Glover, Mark C. Petrie(Copenhagen University Hospital), Lana Dixon, Matthaios Didagelos(Golden Jubilee National Hospital), Novalia Sidik(University Hospitals Bristol NHS Foundation Trust), Simon Walsh(Royal Brompton & Harefield NHS Foundation Trust), Ceri H. Davies, Elliot J. Smith(Barts Health NHS Trust), Christopher A. Rinaldi(King's College London), Jonathon Hinton(Wellcome Sanger Institute), Holly Morgan(King's College London), Abdul Mozid, Margaret McEntegart(Golden Jubilee National Hospital), Julian Strange(NIHR Bristol Cardiovascular Biomedical Research Unit), Amedeo Chiribiri(King's College London), Stuart Watkins(Golden Jubilee National Hospital), Bhavik Modi, Divaka Perera, Louise Cowan, Tim Clayton(London School of Hygiene & Tropical Medicine), Haseeb Rahman, James Spratt(St George's, University of London), Natalia Briceno, Amy Raynsford, Peter O’Kane(Royal Bournemouth Hospital), Brian Clapp, Peter Ludman(University Hospitals Birmingham NHS Foundation Trust), Simon Walsh(Royal Victoria Hospital), Roshan Weerackody(Barts Health NHS Trust), Matthew Li Kam Wa(King's College London), Aadil Shaukat(Golden Jubilee National Hospital), Antonis N. Pavlidis, Jehangir Din(Royal Bournemouth Hospital), Michelle A. Anderson, Gerry Carr‐White, Sophie Arnold, Mark Spence(British Heart Foundation), Jonathan Blaxill, Matthew C. Dodd(London School of Hygiene & Tropical Medicine), Simon Redwood(St Thomas' Hospital), Paul Rocchiccioli(Golden Jubilee National Hospital), John P. Greenwood(University of Leeds)
Cited by 32
Related Papers
Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction
|New England Journal of Medicine|2019|6.8k
Diagnosis of Idiopathic Pulmonary Fibrosis. An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline
|American Journal of Respiratory and Critical Care Medicine|2018|4.1k
Nintedanib in Progressive Fibrosing Interstitial Lung Diseases
|New England Journal of Medicine|2019|2.3k
Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials
|The Lancet Diabetes & Endocrinology|2019|1.6k
Diagnosis of Hypersensitivity Pneumonitis in Adults: An Official ATS/JRS/ALAT Clinical Practice Guideline
|American Journal of Respiratory and Critical Care Medicine|2020|1k